Resistance of human fungal pathogens to antifungal drugs.
暂无分享,去创建一个
[1] Mahmoud A. Ghannoum,et al. Biofilm Formation by the Fungal PathogenCandida albicans: Development, Architecture, and Drug Resistance , 2001, Journal of bacteriology.
[2] K. Ziegelbauer,et al. Multiple Functions of Pmt1p-mediated ProteinO-Mannosylation in the Fungal Pathogen Candida albicans * , 1998, The Journal of Biological Chemistry.
[3] T. C. White,et al. Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] T. C. White,et al. Homozygosity at the Candida albicans MTL locus associated with azole resistance. , 2002, Microbiology.
[5] T. C. White,et al. Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance , 1998, Clinical Microbiology Reviews.
[6] D. Kontoyiannis,et al. Antifungal drug resistance of pathogenic fungi , 2002, The Lancet.
[7] T. C. White,et al. Rapid, Transient Fluconazole Resistance inCandida albicans Is Associated with Increased mRNA Levels of CDR , 1998, Antimicrobial Agents and Chemotherapy.
[8] M. Bard,et al. Sequencing, Disruption, and Characterization of the Candida albicans Sterol Methyltransferase (ERG6) Gene: Drug Susceptibility Studies in erg6 Mutants , 1998, Antimicrobial Agents and Chemotherapy.
[9] J. Wingard,et al. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia , 1997, Antimicrobial agents and chemotherapy.
[10] E. Mellado,et al. Identification of Two Different 14-α Sterol Demethylase-Related Genes (cyp51A and cyp51B) in Aspergillus fumigatus and Other Aspergillus species , 2001, Journal of Clinical Microbiology.
[11] D. Sanglard,et al. A common drug‐responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance , 2002, Molecular microbiology.
[12] M. Raymond,et al. Functional isolation of the Candida albicans FCR3 gene encoding a bZip transcription factor homologous to Saccharomyces cerevisiae Yap3p , 2001, Yeast.
[13] J. Lopez-Ribot,et al. Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients , 2001, Antimicrobial Agents and Chemotherapy.
[14] K. Kuchler,et al. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters , 1995, Antimicrobial agents and chemotherapy.
[15] D. Sanglard,et al. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors , 1996, Antimicrobial agents and chemotherapy.
[16] D. Sanglard,et al. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. , 1997, Microbiology.
[17] B. Wickes,et al. Biofilm Formation by Candida dubliniensis , 2001, Journal of Clinical Microbiology.
[18] C. Beck-Sague,et al. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. , 1993, The Journal of infectious diseases.
[19] D. Denning,et al. Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. , 2002, Fungal genetics and biology : FG & B.
[20] J. Morschhäuser,et al. Targeted gene disruption in Candida albicans wild‐type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates , 2000, Molecular microbiology.
[21] D. Sanglard,et al. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. , 2002, The Lancet. Infectious diseases.
[22] G. Köhler,et al. Activation of the Multiple Drug Resistance GeneMDR1 in Fluconazole-Resistant, Clinical Candida albicans Strains Is Caused by Mutations in atrans-Regulatory Factor , 2000, Journal of bacteriology.
[23] M. Raymond,et al. AP1-mediated Multidrug Resistance in Saccharomyces cerevisiae Requires FLR1 Encoding a Transporter of the Major Facilitator Superfamily* , 1997, The Journal of Biological Chemistry.
[24] V. Gupta,et al. Identification of polymorphic mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance, and its in vitro transcriptional activation , 1998, Current Genetics.
[25] E. Manavathu,et al. Comparative Study of Susceptibilities of Germinated and Ungerminated Conidia of Aspergillus fumigatus to Various Antifungal Agents , 1999, Journal of Clinical Microbiology.
[26] S. Kelly,et al. Molecular basis of resistance to azole antifungals. , 2002, Trends in molecular medicine.
[27] S. Donnelly,et al. Identification and Expression of Multidrug Transporters Responsible for Fluconazole Resistance in Candida dubliniensis , 1998, Antimicrobial Agents and Chemotherapy.
[28] Hidetoshi Takahashi,et al. Identification of Saccharomyces cerevisiae Isoleucyl-tRNA Synthetase as a Target of the G1-specific Inhibitor Reveromycin A* , 2002, The Journal of Biological Chemistry.
[29] M. Klepser,et al. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans. , 1998, The Journal of antimicrobial chemotherapy.
[30] T. Poulos,et al. Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[31] C. van Broeckhoven,et al. Molecular biological characterization of an azole-resistant Candida glabrata isolate , 1997, Antimicrobial agents and chemotherapy.
[32] S. Katiyar,et al. Aspergillus fumigatus CYP51 sequence: potential basis for fluconazole resistance. , 2001, Medical mycology.
[33] David Y. Thomas,et al. Population genomics of drug resistance in Candida albicans , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Dierich,et al. Studies of In Vitro Activities of Voriconazole and Itraconazole against Aspergillus Hyphae Using Viability Staining , 2001, Antimicrobial Agents and Chemotherapy.
[35] A. Goffeau,et al. Functional Expression of Candida albicans Drug Efflux Pump Cdr1p in a Saccharomyces cerevisiae Strain Deficient in Membrane Transporters , 2001, Antimicrobial Agents and Chemotherapy.
[36] Dominique Sanglard,et al. Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents , 1998, Antimicrobial Agents and Chemotherapy.
[37] D. Sanglard,et al. Multiple resistance mechanisms to azole antifungals in yeast clinical isolates. , 1998, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[38] J. Lavandera,et al. Translation Elongation Factor 2 Is Part of the Target for a New Family of Antifungals , 1998, Antimicrobial Agents and Chemotherapy.
[39] D. Sanglard,et al. Role of ATP-Binding-Cassette Transporter Genes in High-Frequency Acquisition of Resistance to Azole Antifungals in Candida glabrata , 2001, Antimicrobial Agents and Chemotherapy.
[40] B. Wickes,et al. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. , 2002, The Journal of antimicrobial chemotherapy.
[41] Ronald N. Jones,et al. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans , 1997, Antimicrobial agents and chemotherapy.
[42] D. Sanglard,et al. The ATP Binding Cassette Transporter GeneCgCDR1 from Candida glabrata Is Involved in the Resistance of Clinical Isolates to Azole Antifungal Agents , 1999, Antimicrobial Agents and Chemotherapy.
[43] M. Ghannoum,et al. Mechanism of Fluconazole Resistance inCandida krusei , 1998, Antimicrobial Agents and Chemotherapy.
[44] Yoshiharu Inoue,et al. Regulation of the Yeast Yap1p Nuclear Export Signal Is Mediated by Redox Signal-Induced Reversible Disulfide Bond Formation , 2001, Molecular and Cellular Biology.
[45] J. Morschhäuser,et al. MDR1-Mediated Drug Resistance inCandida dubliniensis , 2001, Antimicrobial Agents and Chemotherapy.
[46] T. C. White,et al. Resistance Mechanisms in Clinical Isolates of Candida albicans , 2002, Antimicrobial Agents and Chemotherapy.
[47] T. Hallstrom,et al. Multiple Pdr1p/Pdr3p Binding Sites Are Essential for Normal Expression of the ATP Binding Cassette Transporter Protein-encoding Gene PDR5* , 1996, The Journal of Biological Chemistry.
[48] M. Ghannoum,et al. Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance , 1999, Clinical Microbiology Reviews.
[49] D. Sanglard,et al. Experimental Induction of Fluconazole Resistance in Candida tropicalis ATCC 750 , 2000, Antimicrobial Agents and Chemotherapy.
[50] B. Arthington-Skaggs,et al. Antifungal drug susceptibility testing and resistance in Aspergillus. , 1999, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[51] M. Raymond,et al. The bZip Transcription Factor Cap1p Is Involved in Multidrug Resistance and Oxidative Stress Response inCandida albicans , 1999, Journal of bacteriology.